Stay updated on Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision label updated to v3.3.2; the previous v3.3.1 label is no longer displayed.SummaryDifference0.1%

- Check21 days agoChange DetectedAdded 'Revision: v3.3.1' and removed 'Revision: v3.2.0' from the page.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoval of the government funding status notice regarding potential data delays and NIH operations from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedNo significant changes detected on the Study Details page for NCT03612232. The content appears to be the same as before and the page remains focused on Cabozantinib in Advanced Adrenocortical Carcinoma.SummaryDifference0.5%

- Check71 days agoChange DetectedCore content updated: new operating-status notice and latest version (v3.2.0) added; older version tag removed and a specific item (Adrenal cortex carcinoma) deleted.SummaryDifference3%

- Check79 days agoChange DetectedUpdated the page from revision v3.0.2 to v3.1.0, signaling a new release version.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.